Clinical Trial
. 2006 Apr 20;24(12):1957; author reply 1957-8.
doi: 10.1200/JCO.2005.05.0450.
New issues on cetuximab mechanism of action in epidermal growth factor receptor-negative colorectal cancer: the role of vascular endothelial growth factor
- PMID: 16622275
- DOI: 10.1200/JCO.2005.05.0450
Item in Clipboard
Clinical Trial
New issues on cetuximab mechanism of action in epidermal growth factor receptor-negative colorectal cancer: the role of vascular endothelial growth factor
J Clin Oncol.
.
No abstract available
Comment on
-
Cetuximab shows activity in colorectal cancer patients with tumors that do not express the epidermal growth factor receptor by immunohistochemistry.J Clin Oncol. 2005 Mar 20;23(9):1803-10. doi: 10.1200/JCO.2005.08.037. Epub 2005 Jan 27. J Clin Oncol. 2005. PMID: 15677699
Similar articles
-
[Application of monoclonal antibody in combination with irinotecan in the treatment of colorectal cancer].Zhonghua Zhong Liu Za Zhi. 2006 Oct;28(10):796-7. Zhonghua Zhong Liu Za Zhi. 2006. PMID: 17366800 Review. Chinese. No abstract available.
-
New treatment options for colorectal cancer.N Engl J Med. 2004 Jul 22;351(4):391-2. doi: 10.1056/NEJMe048151. N Engl J Med. 2004. PMID: 15269321 No abstract available.
-
Cetuximab in colon cancer.N Engl J Med. 2004 Oct 7;351(15):1575-6; author reply 1575-6. N Engl J Med. 2004. PMID: 15473024 No abstract available.
-
Cetuximab in colon cancer.N Engl J Med. 2004 Oct 7;351(15):1575-6; author reply 1575-6. N Engl J Med. 2004. PMID: 15473023 No abstract available.
-
Synergy between cetuximab and chemotherapy in tumors of the gastrointestinal tract.Oncologist. 2008 Jan;13(1):39-50. doi: 10.1634/theoncologist.2006-0049. Oncologist. 2008. PMID: 18245011 Review.
Cited by
-
Role of cetuximab in first-line treatment of metastatic colorectal cancer.World J Gastroenterol. 2014 Apr 21;20(15):4208-19. doi: 10.3748/wjg.v20.i15.4208. World J Gastroenterol. 2014. PMID: 24764659 Free PMC article. Review.
-
First-line cetuximab versus bevacizumab for RAS and BRAF wild-type metastatic colorectal cancer: a systematic review and meta-analysis.BMC Cancer. 2019 Mar 28;19(1):280. doi: 10.1186/s12885-019-5481-z. BMC Cancer. 2019. PMID: 30922269 Free PMC article.
-
Combination Radioimmunotherapy Strategies for Solid Tumors.Int J Mol Sci. 2019 Nov 8;20(22):5579. doi: 10.3390/ijms20225579. Int J Mol Sci. 2019. PMID: 31717302 Free PMC article. Review.
-
A case of heterogeneous sensitivity to panitumumab in cetuximab-refractory colorectal adenocarcinoma metastases.Cancer Biol Ther. 2015;16(3):377-82. doi: 10.1080/15384047.2015.1004927. Cancer Biol Ther. 2015. PMID: 25695537 Free PMC article.
-
Sensitivity and resistance to EGF-R inhibitors: approaches to enhance the efficacy of EGF-R antibodies.MAbs. 2009 Nov-Dec;1(6):590-9. doi: 10.4161/mabs.1.6.10051. Epub 2009 Nov 11. MAbs. 2009. PMID: 20068398 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Research Materials
